Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027
Description
Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027
The global next-generation sequencing market is projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027. Increasing applications of NGS in cancer research, growing incidence of cancer and launch of new NGS platforms and consumables are some factors projected to drive the growth of the NGS market.
Consumables segment accounted for the largest share of next-generation sequencing market
On the basis of product & service, the next-generation sequencing market segmented into NGS consumables, sequencing services, presequencing products & services, NGS platforms, services for NGS platforms, and bioinformatics. In 2021, NGS consumables accounted for the largest share, owing to recent launch of new reagents and kits, and increasing in number of R&D activities in genomics.
Sequencing by synthesis segment accounted for the largest share of next-generation sequencing market
Based on technology, the next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. In 2021, the sequencing by synthesis segment grabbed largest share in the NGS market owing to launch of new NGS platforms based on sequencing by synthesis technology.
The prominent players in NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China). Other players in the market include Hamilton Company (US), MedGenome (US), Becton, Dickinson and Company (US), Genotypic Technology (India), and LGC Limited (US).
“North America: Accounted for the largest share in the next-generation sequencing market”
North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 80% and Demand Side - 20%
By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%
List of Companies Profiled in the Report:
Illumina (US)
Thermo Fisher Scientific (US)
PerkinElmer (US)
BGI Group (China)
Agilent Technologies (US)
Eurofins Scientific (Luxembourg)
Pacific Biosciences (US)
Oxford Nanopore Technologies (UK)
QIAGEN (Netherlands)
F. Hoffmann-La Roche AG (Switzerland)
Brooks Automation (US)
Psomagen, Inc. (US)
10x Genomics (US)
Tecan Group (Switzerland)
Zymo Research (US)
Takara Bio (Japan)
Promega Corporation (US)
CD Genomics (US)
New England Biolabs (US)
Novogene Corporation (China)
Hamilton Company (US)
MedGenome (US)
Becton, Dickinson and Company (US)
Genotypic Technology (India)
LGC Limited (US)
Research Coverage:
This report provides a detailed picture of the next-generation sequencing market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall next-generation sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
The global next-generation sequencing market is projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027. Increasing applications of NGS in cancer research, growing incidence of cancer and launch of new NGS platforms and consumables are some factors projected to drive the growth of the NGS market.
Consumables segment accounted for the largest share of next-generation sequencing market
On the basis of product & service, the next-generation sequencing market segmented into NGS consumables, sequencing services, presequencing products & services, NGS platforms, services for NGS platforms, and bioinformatics. In 2021, NGS consumables accounted for the largest share, owing to recent launch of new reagents and kits, and increasing in number of R&D activities in genomics.
Sequencing by synthesis segment accounted for the largest share of next-generation sequencing market
Based on technology, the next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. In 2021, the sequencing by synthesis segment grabbed largest share in the NGS market owing to launch of new NGS platforms based on sequencing by synthesis technology.
The prominent players in NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China). Other players in the market include Hamilton Company (US), MedGenome (US), Becton, Dickinson and Company (US), Genotypic Technology (India), and LGC Limited (US).
“North America: Accounted for the largest share in the next-generation sequencing market”
North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 80% and Demand Side - 20%
By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%
List of Companies Profiled in the Report:
Illumina (US)
Thermo Fisher Scientific (US)
PerkinElmer (US)
BGI Group (China)
Agilent Technologies (US)
Eurofins Scientific (Luxembourg)
Pacific Biosciences (US)
Oxford Nanopore Technologies (UK)
QIAGEN (Netherlands)
F. Hoffmann-La Roche AG (Switzerland)
Brooks Automation (US)
Psomagen, Inc. (US)
10x Genomics (US)
Tecan Group (Switzerland)
Zymo Research (US)
Takara Bio (Japan)
Promega Corporation (US)
CD Genomics (US)
New England Biolabs (US)
Novogene Corporation (China)
Hamilton Company (US)
MedGenome (US)
Becton, Dickinson and Company (US)
Genotypic Technology (India)
LGC Limited (US)
Research Coverage:
This report provides a detailed picture of the next-generation sequencing market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall next-generation sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
Table of Contents
456 Pages
- STUDY OBJECTIVES
- MARKET DEFINITION
- MARKET SCOPE
- CURRENCY CONSIDERED
- LIMITATIONS
- STAKEHOLDERS
- SUMMARY OF CHANGES
- RESEARCH APPROACH
- MARKET ESTIMATION METHODOLOGY
- MARKET GROWTH RATE PROJECTIONS
- DATA TRIANGULATION
- RESEARCH ASSUMPTIONS
- RISK ANALYSIS
- RECESSION IMPACT
- EXECUTIVE SUMMARY
- NEXT-GENERATION SEQUENCING MARKET OVERVIEW
- NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)
- NEXT-GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2022 VS. 2027
- NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- INTRODUCTION
- MARKET DYNAMICS
- TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- PRICING ANALYSIS
- TECHNOLOGY ANALYSIS
- VALUE CHAIN ANALYSIS
- ECOSYSTEM ANALYSIS
- KEY CONFERENCES AND EVENTS IN 2023-2024
- PORTER'S FIVE FORCES ANALYSIS
- KEY STAKEHOLDERS AND BUYING CRITERIA
- PATENT ANALYSIS
- REGULATORY ANALYSIS
- INTRODUCTION
- NGS CONSUMABLES
- SEQUENCING SERVICES
- PRE-SEQUENCING PRODUCTS & SERVICES
- NGS PLATFORMS
- BIOINFORMATICS
- SERVICES FOR NGS PLATFORMS
- INTRODUCTION
- SEQUENCING BY SYNTHESIS
- ION SEMICONDUCTOR SEQUENCING
- NANOPORE SEQUENCING
- SINGLE-MOLECULE REAL-TIME SEQUENCING
- OTHER SEQUENCING TECHNOLOGIES
- INTRODUCTION
- DIAGNOSTICS
- DRUG DISCOVERY AND DEVELOPMENT
- AGRICULTURAL AND ANIMAL RESEARCH
- OTHER APPLICATIONS
- INTRODUCTION
- ACADEMIC INSTITUTES AND RESEARCH CENTERS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- HOSPITALS AND CLINICS
- REFERENCE LABORATORIES
- OTHER END USERS
- INTRODUCTION
- NORTH AMERICA
- EUROPE
- ASIA PACIFIC
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- INTRODUCTION
- RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
- REVENUE ANALYSIS
- MARKET SHARE ANALYSIS
- COMPANY EVALUATION MATRIX
- COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
- COMPANY EVALUATION MATRIX FOR START-UPS/SMES
- COMPETITIVE BENCHMARKING OF START-UPS/SMES
- COMPETITIVE SCENARIO AND TRENDS
- KEY PLAYERS
- OTHER COMPANIES
- DISCUSSION GUIDE
- KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- CUSTOMIZATION OPTIONS
- RELATED REPORTS
- AUTHOR DETAILS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
